Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis
Go back to Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis| AMERICAN RCT REIT (NASDAQ: ARCT) | Delayed: 5.79 -0.14 (2.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.93 | 52 Week High | $13.09 | |||
| Open | $5.87 | 52 Week Low | $5.54 | |||
| Day High | $5.91 | P/E | N/A | |||
| Day Low | $5.74 | EPS | $-0.38 | |||
| Volume | 352,259 | |||||

